Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer

  • Mohammed Sedki, Islam A. Khalil, Ibrahim M. El-Sherbiny
  • Artificial Cells Nanomedicine and Biotechnology, October 2018, Taylor & Francis
  • DOI: 10.1080/21691401.2018.1505743

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/21691401.2018.1505743

The following have contributed to this page: Professor Ibrahim M. El-Sherbiny